Product Information
BUTRANS 7.5 MCG/HR PATCH is a brand product labeled by Purdue Pharma LP, priced at $68.8220 per EA under NDC 59011075704. Its NADAC has been published 616 times since Dec 17, 2014.
FDA first approved this application on Jun 30, 2010. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
7.5 ug/h
Manufacturer
Purdue Pharma LPNDC
59011075704
Classification
Brand
Dosage Form
PATCH, EXTENDED RELEASE
Route
TRANSDERMAL
Effective Date
9/23/2026
Active Ingredients
BUPRENORPHINEApproval Type
New Drug (NDA)
FDA Application
NDA021306FDA Approved
6/30/2010
TE Code
AB
On Market Since
2/14/2011
Pharmacological Classes
Price Statistics
The NADAC for BUTRANS 7.5 MCG/HR PATCH has been published 616 times since Dec 17, 2014, and over the history we have for it it has risen 20.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $68.8220 per EA |
|---|---|
| All-time high | $119.3393 (Dec 27, 2023) |
| All-time low | $57.1825 (Dec 17, 2014) |
| 52-week high | $68.8366 |
| 52-week low | $68.7370 |
| Median price | $90.1248 |
| Average price | $88.6458 |
| Largest weekly change | -42.5% (Jan 3, 2024) |
| Weeks tracked | 616 |
| Tracking since | Dec 17, 2014 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the buprenorphine market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Purdue Pharma LP manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
buprenorphine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Partial Opioid Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of BUTRANS 7.5 MCG/HR PATCH?
The current National Average Drug Acquisition Cost (NADAC) for BUTRANS 7.5 MCG/HR PATCH, manufactured by Purdue Pharma LP, is $68.8220 per EA (NDC 59011075704), effective Sep 30, 2026.
How has the price of BUTRANS 7.5 MCG/HR PATCH changed over time?
Over the history we have for it, the NADAC for BUTRANS 7.5 MCG/HR PATCH has risen 20.4%. It has been tracked across 616 weekly CMS publications since Dec 17, 2014.
What are the highest and lowest recorded NADAC prices for BUTRANS 7.5 MCG/HR PATCH?
Since Dec 17, 2014, the NADAC for BUTRANS 7.5 MCG/HR PATCH has ranged from a low of $57.1825 (Dec 17, 2014) to a high of $119.3393 (Dec 27, 2023), with a median of $90.1248 per EA.
Are there cheaper alternatives to BUTRANS 7.5 MCG/HR PATCH?
No other NADAC-published product currently shares the active ingredient and strength of BUTRANS 7.5 MCG/HR PATCH in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures BUTRANS 7.5 MCG/HR PATCH?
BUTRANS 7.5 MCG/HR PATCH (NDC 59011075704) is labeled by Purdue Pharma LP, and CMS classifies it as a brand product.